Amlodipine And Valsartan
Product Images NDC 45865-890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (890)

Pdp (890)
This is a product description for the medication Amlodipine & Valsartan available in tablet form with a strength of 5/320mg. The tablets serve as a generic alternative for a medication called Exforge. The text also includes a manufacturer's name, Srurobiido Pharla TD, and a warning not to take the medication if not prescribed by a physician.*
FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlo Val Fig2)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlo Val Fig2)
This is a graph showing the probability of achieving Diastolic Blood Pressure (DBP) lower than 90 mmHg at Week 8 with Amiodipine and Valsartan Tablets at 10 mg/320 mg. The graph includes baseline DBP values ranging from 100 to 110 mmHg. There is also a mention of Valsartan 320 mg, Amiodipine 10 mg, and placebo.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlo Val Fig3)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlo Val Fig3)
This document appears to be a medical report showing a chart with the probability of achieving a systolic blood pressure of less than 130 mmHg after taking Amlodipine and Valsartan tablets that contain 10mg Amiodipine and 320mg Valsartan. The chart is based on a baseline systolic blood pressure measurement taken at Week 8. There is also a placebo listed in the ingredients but no additional information is available.*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlo Val Fig4)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlo Val Fig4)
The text describes a graph showing the probability of achieving a diastolic blood pressure of less than 80 mmHg at week 8 for a combination of Amlodipine and Valsartan tablets with 10mg and 320mg doses respectively, compared to a placebo. The graph shows baseline DBP values of 100, 105, and 110 and has no other discernible information.*
FDA Label Image

Chemical Structure1 (Amlo Val Str1)

Chemical Structure1 (Amlo Val Str1)
FDA Label Image

Chemical Structure2 (Amlo Val Str2)

Chemical Structure2 (Amlo Val Str2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.